Brodalumab 68225-0086
Product NDC
68225-0086- Manufacturer
- Patheon Italia S.p.a.
- Dosage Form
- Injection
- Product Type
- Drug For Further Processing
- Marketing Start
- February 15, 2017
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Brodalumab | 210 mg/1 |
Packaging Options(1)
14688 SYRINGE in 1 CONTAINER (68225-086-00) / 1 INJECTION in 1 SYRINGE